Impact of the COVID-19 outbreak on the field of hematopoietic cell transplantation in the Asia-Pacific region: APBMT Activity Survey 2020/2021
Rattachement africain : jp, sg, cn, kr, in, ir, tw, my, th, pk, lk, ph, mm, id, np, bd, mn, ru, au. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
COVID-19 became a global pandemic in 2020 and significantly affected the activity of hematopoietic cell transplants (HCT) worldwide. Despite these challenges, a total of 28,793 transplants, including 18,518 allogeneic and 10,275 autologous transplants, were performed in 719 facilities in 2020 in the Asia-Pacific (AP) region. This represented a 5.1% increase in allogeneic transplants and a 3.1% increase in autologous transplants, an overall increase of 4.4% compared to the numbers in 2019. With respect to the donor source, haploidentical transplants increased significantly by 18.6%, related transplants by 8.8%, and cord blood transplants (CBT) by 9.2%. However, the number of unrelated transplants, excluding CBT, decreased for the first time by 8.2%. As a result, COVID-19 facilitated the growth of haploidentical transplants due to cross-border restrictions. Regarding the changes in the total number of transplants by country/region in 2020, it increased by 2,048 transplants in China, followed by Japan (210 transplants) and Korea (230 transplants); however, 14 of the 22 countries and regions decreased their number of transplants in 2020 compared to the previous year. There was no correlation between the increase or decrease in the number of transplants in 2020 and the Gross National Income (GNI) per capita of each country/region in 2020, as well as Domestic General Government Health Expenditure as a percentage of General Government Expenditure (GGHE-D/GGE). In 2021, the total number of transplants in this region was 34,754. With the exception of a few countries/regions that decreased the number of transplants in 2020, most countries/regions have started to see a recovery in 2021. The COVID-19 pandemic significantly affected the supply chain and logistics involved in HCT rather than its numbers; however, we have found ways to overcome logistical challenges to carry out transplant medicine without delay, even under these circumstances.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Impact of the COVID-19 outbreak on the field of hematopoietic cell transplantation in the Asia-Pacific region: APBMT Activity Survey 2020/2021
- Date Crossref
- 01/01/2024
- Éditeur
- Asia-Pacific Blood and Marrow Transplantation Group
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Aichi Medical University Department of Promotion for Blood and Marrow Transplantation pays non établi dans la noticeUniversité ou école supérieure
-
Singapore General Hospital Department of Hematology pays non établi dans la noticeÉtablissement de santé
-
Peking University Department of Hematology pays non établi dans la noticeUniversité ou école supérieure
-
Zhejiang University pays non établi dans la noticeUniversité ou école supérieure
-
Nagoya University Hospital Department of Advanced Medicine pays non établi dans la noticeÉtablissement de santé
-
Kyungpook National University Hospital Department of Internal Medicine pays non établi dans la noticeÉtablissement de santé
-
Korea University Department of Internal Medicine pays non établi dans la noticeUniversité ou école supérieure
-
The Catholic University of Korea Seoul St. Mary's Hospital Seoul St. Mary's Hospital pays non établi dans la noticeÉtablissement de santé
-
Catholic University of Korea pays non établi dans la noticeUniversité ou école supérieure
-
Tata Medical Center Department of Oncology pays non établi dans la noticeOrganisme public
-
Advanced Centre for Treatment pays non établi dans la noticeÉtablissement de santé
-
Christian Medical College Department of Hematology pays non établi dans la noticeUniversité ou école supérieure
Department of Promotion for Blood and Marrow Transplantation — Aichi Medical University, Department of Hematology — Singapore General Hospital et Department of Hematology — Peking University, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.